← All trials
NCT06523530
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 31, 2024
- Primary completion
- Oct 31, 2026
- Completion date
- Apr 30, 2027
- First posted
- Jul 26, 2024
- Last posted
- Jul 30, 2024
- Enrollment
- 62
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Aristotle University of ThessalonikiLead sponsor
- Hellenic ArmyOfficial
- Government of GreeceCollaborator
- Aristotle University of ThessalonikiSponsor investigator
- Aristotle University of ThessalonikiOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.